CryoCor Sees Opportunity With A-Fib Ablation Label; Do Physicians Agree?
This article was originally published in The Gray Sheet
Executive Summary
CryoCor hopes its lead in the race to gain an atrial fibrillation indication for an ablation catheter will translate into a market advantage, but first it will need to change what it says are misperceptions among some physicians about the limitations of cryoenergy